For the Inventor, By the Inventor

Enter inventor name

East Windsor, NJ, United States of America

Victor W Rosso

USPTO Granted Patents = 13 (Patent Applications = 4)

CIPO Patents = 2 (Patent Applications = 3)

EPO Patents = 7 (Patent Applications = 11)

Average Co-Inventor Count = 3.7

ph-index = 3

Forward Citations = 20(Granted Patents)

Location History:

East Windsor, NJ (US) (2001 - 2017)
Monroe Township, NJ (US) (2021 - 2023)

Company Filing History:

12 out of 3,681

Bristol-myers Squibb Compnay

Innate Tumor Immunity, Inc.

Amira Pharmaceuticals, Inc.

where one patent can have more than one assignee

Years Active: 2001-2024

where 'Filed Patents' based on already Granted Patents

13 patents (USPTO):Sort by Forward Citations

Abstract keywords

1. 12129245 - Crystal form of 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d) pyridazine-3-carboxamide (2024-10-29),

2. 11572360 - Substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds and improved methods for their preparation (2023-02-07),

3. 10899745 - Process for the preparation of 6-(cyclopropaneamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl)amino)-N-(methyl-d3)pyridazine-3-carboxamide (2021-01-26),

4. 9556133 - Polycyclic LPA1 antagonist and uses thereof (2017-01-31),

5. 9173879 - Crystalline forms of (S)-7-([1,2,4]triazolo[1,5-a ]pyridin-6-yl)-4-(3,4-dichlorophenyl)-1,2,3,4-tetrahydroisoquinoline and use thereof (2015-11-03),

6. 8815894 - [object Object] (2014-08-26),

7. 8383812 - [object Object] (2013-02-26),

8. 7388098 - Dynamic resolution of isomers and resolved isomers (2008-06-17),

9. 7371864 - Crystalline forms of a factor Xa inhibitor (2008-05-13),

10. 6968037 - High throughput X-ray diffraction filter sample holder (2005-11-22),

11. 6893613 - Parallel chemistry reactor with interchangeable vessel carrying inserts (2005-05-17),

12. 6783737 - High pressure chemistry reactor (2004-08-31),

13. 6184395 - Reaction conditions for the cleavage of silyl ethers in the preparation of paclitaxel(taxol®) and paclitaxel analogues (2001-02-06),

Title: Victor W. Rosso: A Pioneering Inventor in Pharmaceutical Innovations

Introduction

Victor W. Rosso, based in East Windsor, NJ, is a noteworthy inventor with an impressive portfolio of 13 patents. His work primarily focuses on advancements in the pharmaceutical field, particularly in creating innovative compounds and enhancing their preparation methods. Rosso's contributions are significant in developing therapies that target key areas in medical science.

Latest Patents

Among Victor W. Rosso's latest patents is the innovative crystalline form, specifically Form E of the compound 6-(cyclopropanecarboxamido)-4-((2-methoxy-3-(1-methyl-1H-1,2,4-triazol-3-yl)phenyl) amino)-N-(methyl-d)pyridazine-3-carboxamide. This discovery details the characteristics of a neat crystalline form and is critical in pharmaceutical applications. Additionally, he has made strides in the development of substituted 4-amino-1H-imidazo[4,5-c]quinoline compounds, providing improved methods for their synthesis. These compounds have been identified as useful NLRP3 modulators, highlighting their potential therapeutic implications.

Career Highlights

Victor W. Rosso has garnered substantial experience through his roles in leading pharmaceutical companies such as Bristol-Myers Squibb Company and Amira Pharmaceuticals, Inc. His expertise in drug development and innovation has earned him recognition within the industry. His patents reflect both creativity and scientific rigor, setting a foundation for future advancements in drug therapies.

Collaborations

Throughout his career, Rosso has collaborated with esteemed colleagues, including Joseph Nolfo and John J. Venit. These partnerships have contributed to his success and the advancement of pharmaceutical innovations, fostering an environment of creativity and scientific exploration.

Conclusion

Victor W. Rosso stands out as an influential figure in the realm of pharmaceutical inventions. His array of patents, combined with extensive career experiences and collaborations, showcases his dedication to enhancing medical treatments. As innovations continue to evolve, Rosso's work remains pivotal in shaping the future of drug development and therapeutic applications.

This text is generated by artificial intelligence and may not be accurate.

Please report any incorrect information to support@idiyas.com

Loading…